Use of these codes has frequently raised concerns for compliance due to a lack of clarity regarding when they’re appropriate.
New study shows that ctDNA liquid biopsy testing after stage II colon cancer may determine whether chemotherapy is required.
The owner, who also owned several telemarketing companies and committed tax evasion of just over $4 million, now faces 14 years in prison.
The American Society for Gastrointestinal Endoscopy releases new recommendations for screening those with genetic susceptibility.
The company was facing allegations that it had intentionally delayed submitting lab tests in order to circumvent the rule and receive payment.
Caris Life Sciences agrees to pay $2.8 million to settle claims that it purposely delayed submitting lab tests to get around Medicare’s 14-day rule.
Here are the two key CLFS changes, set to take effect on July 1, 2022, that your billing staff needs to know about.
If your lab received federal relief funds from the US government during the COVID-19 pandemic, you could be at risk of FCA lawsuits.
The most recent congressional effort to pass LDT legislation may prove to be the one that finally comes to fruition.
IDT will distribute the automated Biomek NGeniuS instrument in the US, Canada, UK, Sweden, Germany, France, Austria, and the Netherlands.
Agilent and Genomenon team up to bring users more effective software and search tools for making a genetic diagnosis.
Bringing the Specific Reveal Rapid AST system into the fold enhances French firm’s global position in clinical microbiology.
In this Labs in Court Weekly Roundup, all the main health care-related cases involved False Claims Act allegations or charges.